Hussam Ashab
Hussam Ashab
Data scientist
Verified email at alumni.duke.edu - Homepage
Title
Cited by
Cited by
Year
Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy
R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ...
European urology 72 (4), 544-554, 2017
4202017
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
SG Zhao, SL Chang, DE Spratt, N Erho, M Yu, HAD Ashab, M Alshalalfa, ...
The lancet oncology 17 (11), 1612-1620, 2016
1282016
Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome
S You, BS Knudsen, N Erho, M Alshalalfa, M Takhar, HA Ashab, ...
Cancer research 76 (17), 4948-4958, 2016
912016
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
R Stoyanova, A Pollack, M Takhar, C Lynne, N Parra, LLC Lam, ...
Oncotarget 7 (33), 53362, 2016
712016
An augmented reality system for epidural anesthesia (area): Prepuncture identification of vertebrae
HAD Ashab, VA Lessoway, S Khallaghi, A Cheng, R Rohling, ...
IEEE transactions on biomedical engineering 60 (9), 2636-2644, 2013
272013
Real-time ultrasound image classification for spine anesthesia using local directional Hadamard features
M Pesteie, P Abolmaesumi, HAD Ashab, VA Lessoway, S Massey, ...
International journal of computer assisted radiology and surgery 10 (6), 901-912, 2015
172015
AREA: An augmented reality system for epidural anaesthesia
HAD Ashab, VA Lessoway, S Khallaghi, A Cheng, R Rohling, ...
2012 Annual International Conference of the IEEE Engineering in Medicine and …, 2012
142012
Multimodal classification of prostate tissue: a feasibility study on combining multiparametric MRI and ultrasound
HAD Ashab, NF Haq, G Nir, P Kozlowski, P Black, EC Jones, ...
Medical Imaging 2015: Computer-Aided Diagnosis 9414, 94141B, 2015
72015
Development and validation of a prostate cancer genomic signature that predicts early ADT treatment response following radical prostatectomy
RJ Karnes, V Sharma, V Choeurng, HAD Ashab, N Erho, M Alshalalfa, ...
Clinical Cancer Research 24 (16), 3908-3916, 2018
62018
Relationships between an androgen receptor output signature (ARoS), AR expression, and poor prostate cancer prognosis in RP tissues.
M Alshalalfa, M Santiago-Jimenez, N Erho, N Fishbane, K Yousefi, ...
Journal of Clinical Oncology 35 (6_suppl), 38-38, 2017
52017
Solutions for missing parameters in computer-aided diagnosis with multiparametric imaging data
HAD Ashab, P Kozlowski, SL Goldenberg, M Moradi
International Workshop on Machine Learning in Medical Imaging, 289-296, 2014
42014
Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy.
DT Miyamoto, E Gibb, KW Mouw, Y Liu, CL Wu, M Drumm, J Lehrer, ...
Journal of Clinical Oncology 36 (6_suppl), 513-513, 2018
32018
Ultrasound guidance for epidural anesthesia
HAD Ashab
University of British Columbia, 2013
32013
Subtyping muscle-invasive bladder cancer to assess clinical response to trimodality therapy
JA Efstathiou, E Gibb, DT Miyamoto, CL Wu, MR Drumm, J Lehrer, ...
International Journal of Radiation Oncology, Biology, Physics 99 (2), S118, 2017
22017
Use of a genetic signature diagnostically to evaluate treatment strategies for prostate cancer
HAD Ashab, N Erho, M Alshalalfa, E Davicioni
US Patent App. 15/765,711, 2018
12018
Muscle invasive bladder cancer: a single sample patient assay to predict molecular subtypes and benefit of neoadjuvant chemotherapy
R Seiler, HAD Ashab, N Erho, BW Van Rhijn, B Winters, J Douglas, ...
European Urology Supplements 3 (16), e1567-e1568, 2017
12017
A 24-Gene Predictor of Response to Postoperative Radiation Therapy in Prostate Cancer
SG Zhao, SL Chang, DE Spratt, NG Erho, M Yu, H Ashab, K Yousefi, ...
International Journal of Radiation Oncology, Biology, Physics 96 (2), S104-S105, 2016
12016
The frequency of druggable targets in localized prostate cancer: initial analysis from a commercially available genomic expression database in urologic cancer
RB Den, E Davicioni, M Takhar, NG Erho, L Lam, H Ashab, A Olson, ...
International Journal of Radiation Oncology• Biology• Physics 96 (2), E251-E252, 2016
12016
Development and validation of genomic signature to predict ADT treatment failure.
J Karnes, HAD Ashab, BJ Trock, A Ross, H Tsai, JJ Tosoian, M Alshalalfa, ...
Journal of Clinical Oncology 34 (15_suppl), 5018-5018, 2016
12016
Development and validation of an ADT resistance signature to predict adjuvant hormone treatment failure.
J Karnes, HAD Ashab, BJ Trock, A Ross, H Tsai, JJ Tosoian, N Erho, ...
Journal of Clinical Oncology 34 (2_suppl), 106-106, 2016
12016
The system can't perform the operation now. Try again later.
Articles 1–20